Hepatitis b surface antigen

Recombivax HB

40 MCG / ML SuspensionCanadaMarketedAuthorised 24 Oct 2002

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Heplisav BEuropean Union · Dynavax GmbHSame substance
PreHevbriEuropean Union · VBI Vaccines B.V.Same substance
Engerix-B Suspension for Injection in Prefilled Syringe 20MCG/MLSingapore · 20 mcg/mL · injection, suspension · Glaxosmithkline Pte LTDSame substance
ENGERIX-B SUSPENSION FOR INJECTION IN PREFILLED SYRINGE 10mcg/0.5mlSingapore · 10 mcg/0.5ml · injection, suspension · Glaxosmithkline Pte LTDSame substance
Lgvac-B Hepatitis B VaccineTaiwan · 注射劑 · 保生製藥股份有限公司科學園區分公司Same substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Hepatitis b surface antigen

Recombivax HB

40 MCG / ML SuspensionCanadaMarketedAuthorised 24 Oct 2002

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Hepatitis b surface antigen
Strength: 40 MCG / ML
Dosage form: Suspension
Route: Intramuscular
Register: Canada (Health Canada)
Status: Marketed
Authorised: 24 Oct 2002
Registration: DIN 02245977
Marketing authorisation holder: Merck Canada INC
ATC code: J07BC01
Group: Anti-infectives for systemic use
Supply: SCHEDULE D

Recombivax HBHepatitis b surface antigen · 5 MCG / 0.5 ML · SolutionCanada

Recombivax HBHepatitis b surface antigen · 10 MCG / 1 ML · SolutionCanada

PrehevbrioHepatitis b surface antigen · 10 MCG / ML · SuspensionCanada

Engerix-BHepatitis b surface antigen · 20 MCG / 1 ML · SuspensionCanadaCancelled

Engerix-BHepatitis b surface antigen · 10 MCG / 0.5 ML · SuspensionCanadaCancelled

Recombivax HBHepatitis b surface antigen · 10 MCG / ML · SuspensionCanadaCancelled

Recombivax HB (Adult Dialysis with Preservative)Hepatitis b surface antigen · 40 MCG / ML · SolutionCanadaCancelled

Recombivax HB (With Preservative)Hepatitis b surface antigen · 10 MCG / ML · SolutionCanadaCancelled